Table 2.
Measure | Screening | Baseline (after intervention) | 3 months (during intervention) | 6 months (immediately after intervention) | 18 months (12 months after intervention) |
---|---|---|---|---|---|
Primary objective | |||||
Cognitive assessment | X | X | X | ||
Secondary objectives | |||||
Blood sample | X | X | X | ||
Gene expression | X | X | X | ||
Biomarkers | X | X | X | ||
Brain MRI | X | X | X | ||
Mediating/moderating variables, covariates, and descriptive data | |||||
Fitness Testing (VO2max) | X | X | X | X | |
Mini–Mental State Examination | X | ||||
DXA | X | X | X | X | |
Height and weight | X | X | X | X | |
Blood pressure | X | X | X | X | |
Questionnaires | |||||
IPAQ | X | X | X | X | X |
SF-36 | X | X | X | X | |
DASS | X | X | X | X | |
CHAMPS | X | X | X | X | |
CCV FFQ | X | X | X | X | |
PSQI | X | X | X | X | |
GDS | X | ||||
Medical history and demographic information | X | ||||
Genotyping | X |
Abbreviations: CCV FFQ, Cancer Council of Victoria Food Frequency Questionnaire; CHAMPS, Community Healthy Activities Model Program for Seniors; DASS, Depression, Anxiety and Stress Scale; DXA, dual-energy X-ray absorptiometry; GDS, Geriatric Depression Scale; IPAQ, International Physical Activity Questionnaire; MRI, magnetic resonance imaging; PSQI, Pittsburgh Sleep Quality Index; SF-36, short-form health survey; VO2max, maximal oxygen consumption.